FcγRIIa polymorphism in systemic lupus erythematosus (SLE): No association with disease

Clinical and Experimental Immunology

Volumn 104, Issue 2, 1996, Pages 264-268

  Botto, M ^a   Theodoridis, E ^a   Thompson, E M ^a   Beynon, H L C ^a   Briggs, D ^b   Isenberg, D A ^b   Walport, M J ^a   Davies, K A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Fc receptor; Polymorphism; Systemic lupus erythematosus

Indexed keywords

FC RECEPTOR;

ALLOTYPE; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029981461     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.33740.x     Document Type: Article

References (14)

1. Kimberly RP, Salmon JF, Edberg JC. Receptors for immunoglobulin G: molecular diversity and implications for disease. Arthritis Rheum 1995; 38:306-14.
2. Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH. Defective reticuloendothelial system Fc-receptor function in sys temic lupus erythematosus. N Engl J Med 1979; 300:518-23.
3. Salmon JE, Brogle N, Edberg JC, Kimberly RP. Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB; independent mechanisms for differences in human phagocyte function. J Clin Invest 1992; 89:1274-81.
4. Warmerdam PAM, van de Winkel JGJ, Gosselin EJ, Capel PJ. Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J Exp Med 1990; 172:19-25.
5. Blasini AM, Stekman IL, Leon-Ponte M, Caldera D, Rodriguez MA. Increased proportion of responders to a murine anti-CD3 monoclonal antobody of the IgG1 class in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1993; 94:423-8.
6. Duits AJ, Bootsma H, Derksen RHWM et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythemalosus patients. Arthritis Rheum 1995; 39:1832-6.
7. Salmon JE, Millard SS, Arnett FC, Ramsey-Goldman R, McKenzie S, Reilly A, Kimberly RP. FcγRIIa is a non-MHC heritable risk factor for SLE in African-Americans. Arthritis Rheum 1994; 37 (Suppl. 9): S167 (Abstr.).
8. Brooks DG, Qiu WQ, Luster AD, Ravetch JV. Structure and expression of human IgG FcγRII (CD32); functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J Exp Med 1989; 170:1369-85.
9. Roman-Roman S, Ferradim L, Azocar J, Genevee C, Hercend T, Triebel F. Studies on the human T cell receptor α/β variable region genes: 1. Identification of 7 additional Vα subfamilies and 14 Jα segments. Eur J Immunol 1991; 21:927-33.
10. Osborne JM, Chacko GW, Brandt JT, Anderson CL. Ethnic-variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele-specitic oligonucleotide probes. J Immunol Methods 1994; 173:207-17.
11. Davies KA, Schifferli JA, Walport MJ. Complement deficiency and immune complex disease. Spring Sem Immunopathol 1994; 15:397-416.
12. Davies KA, Peters AM, Beynon MLC, Walport MJ. Immune complex processing in systemic lupus erythemalosus-in vivo imaging and clearance studies. J Clin Invest 1992; 90:2075-83.
13. Harley JB, Sheldon P, Neas B et al. Systemic lupus erythematosus: considerations for a genetic approach. J Invest Dermatol 1994; 103 (S5): 144-9.
14. Musser JM, Kroll JS, Granoff DM et al. Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis 1990; 12:75-111.